Canadian AI lab Cohere has announced plans to acquire German AI startup Aleph Alpha. Schwarz Group — a key backer of Aleph Alpha — plans to invest $600 million in Cohere's upcoming Series E round as ...

A deadly crash shut down the northbound 101 Freeway in the Woodland Hills area for several hours early Wednesday morning. The two-vehicle collision was reported just before 1:30 a.m. near Valley ...

There was — and is — no-one like Michael Jackson. Nearly 17 years after his death at age 50 in 2009, the pop superstar's music and art continues to electrify, even as his unprecedented fame, shrouded ...

You’re reading The New Yorker’s daily newsletter, a guide to our top stories, featuring exclusive insights from our writers and editors. Sign up to receive it in your inbox. One of Donald Trump’s ...

A reckless incident at a party throws a young girl’s life into turmoil in this extraordinary third feature from Julia Ducournau. By Jeannette Catsoulis When you purchase a ticket for an independently ...

Recent developments in generative artificial intelligence have educators from elementary to university seemingly fighting an uphill battle as they struggle to manage students’ dependence on the ...

CALABASAS, Calif. (KABC) -- A deadly crash involving a semi-truck and a pedestrian forced the closure of most eastbound lanes of the 101 Freeway in the Calabasas area for several hours Monday morning.

Contrary to popular belief, WWE television isn't terrible at the moment. Rather, it's perfectly fine, but that's also part of the problem. The Road to WrestleMania should be when WWE is putting out ...

If there's anything I miss in pop culture, it's the presence of ordinary movies. I don't mean blockbusters like Avatar or cultural events like Barbenheimer or Oscar contenders like One Battle After ...

Despite a solid cast and pedigree of its own, a Los Angeles crime saga borrows all its best moves from Michael Mann. By Ben Kenigsberg When you purchase a ticket for an independently reviewed film ...

Absci Corporation leverages AI for drug development, with clinical data already produced by ABS-101 and ahead for ABS-201 in 2026. ABS-101, an anti-TL1A antibody, might have fallen a little short of ...